Short Interest in BlackRock Health Sciences Term Trust (NYSE:BMEZ) Increases By 25.1%

BlackRock Health Sciences Term Trust (NYSE:BMEZ) saw a significant growth in short interest during the month of February. As of February 15th, there was short interest totalling 174,400 shares, a growth of 25.1% from the January 31st total of 139,400 shares. Based on an average daily volume of 447,900 shares, the short-interest ratio is currently 0.4 days.

BlackRock Health Sciences Term Trust Price Performance

BMEZ stock traded up $0.02 during trading on Friday, hitting $15.50. 146,079 shares of the company’s stock traded hands, compared to its average volume of 415,561. BlackRock Health Sciences Term Trust has a 52 week low of $14.27 and a 52 week high of $16.75. The business has a fifty day simple moving average of $15.72 and a 200 day simple moving average of $15.67.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Monday, March 31st. Shareholders of record on Friday, March 14th will be given a dividend of $0.1763 per share. This represents a $2.12 dividend on an annualized basis and a yield of 13.65%. The ex-dividend date of this dividend is Friday, March 14th.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

Hedge funds have recently bought and sold shares of the business. Penserra Capital Management LLC bought a new position in shares of BlackRock Health Sciences Term Trust in the third quarter worth about $15,390,000. Raymond James Financial Inc. bought a new stake in shares of BlackRock Health Sciences Term Trust during the fourth quarter valued at approximately $10,869,000. Absolute Investment Advisers LLC purchased a new stake in shares of BlackRock Health Sciences Term Trust in the fourth quarter valued at approximately $3,941,000. CF Capital LLC bought a new position in BlackRock Health Sciences Term Trust in the fourth quarter worth approximately $3,743,000. Finally, Wolverine Asset Management LLC increased its holdings in BlackRock Health Sciences Term Trust by 496.1% during the 4th quarter. Wolverine Asset Management LLC now owns 187,617 shares of the company’s stock worth $2,702,000 after purchasing an additional 156,141 shares during the period.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.